Trade Mark Journal No.2019/052 27 December 2019

WO0000001504629 (5)

Office of origin: United States of America

Date of International Registration:25 October 2019
Date of designation in the UK: 25 October 2019
Image for mark 1504629 REZUROCK

International priority date claimed: 25 April 2019 (United States of America) (88401751)
Class 5
Pharmaceutical preparations and pharmaceutical agents.

Kadmon Pharmaceuticals, LLC

Representative: Michael J. Leonard Fox Rothschild LLP, 997 Lenox Drive, Bldg. 3, Lawrenceville NJ 08648-2311, UNITED STATES OF AMERICA